Research Article of International Journal of Hospital Pharmacy
Art (Anti Retroviral Therapy) Induced Buffalo Hump: Case Report
G.Sravani1, D. Seethram babu1, T.S.Durga Prasad2
1Pharm D Intern, Department of Pharmacy Practice, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati; 2Assistant Professor, Department of Pharmacy Practice, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati
INTRODUCTION- Anti-retroviral therapy is used for the treatment of patients with HIV. This therapy may also lead to some of the adverse drug reactions among which Zidovudine induced Buffalo Hump is an uncommon adverse drug reaction.
CASE REPORT- In this present study a 38 year old women diagnosed with HIV disease in November 2008 and on ZLN therapy. By 2017 December she developed Buffalo Hump in her dorsal cervical area which was not associated with pain and erythema but discomfort is being observed. Patients was suggested for surgical removal of buffalo hump adipose tissue, but she refused to that. Later after six months of follow up the stabilization of fat in cervical region was observed.
CONCLUSION- Protease inhibitors induced Buffalo hump is common but Ziduvudine induced Buffalo hump is uncommon. Treatment options include surgical removal of fat and exercise in order to maintain body fat.
Keywords: Buffalo Hump, Zidovudine, Adverse drug reaction, Anti-retroviral therapy.
How to cite this article:
G.Sravani, D. Seethram babu, T.S.Durga Prasad. Art (Anti Retroviral Therapy) Induced Buffalo Hump: Case Report. International Journal of Hospital Pharmacy, 2018,3:16.
1. Giancarlo Ceccarelli, Gabriella d’Ettorre, Francesco Marchetti, Cecilia Rizza, Claudio M Mastroianni, Bruno Carlesimo, Vincenzo Vullo: Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature: Journal of Medical Case reports, 2011, 5(70): 1-4.
2. Walter Peters PhD MD FRCSC, Anne Phillips MD FRCSC: Buffalo hump and HIV-1 infection: Current concepts and treatment of a patient with the use of suction-assisted lipectomy: Canadian Journal of Plastic Surgery, 1999, 3(7): 129-131.
3. Agrawal P, Gautam A, Chandra S, Aneez A, Gupta A: “Buffalo Hump” in a Female on Zidovudine-Based Antiretroviral Therapy: A Case Report: Indian Journal of Clinical Practice, 2013, 24(7): 649-650.
4. Mallon PW, Wand H, Law M, Miller J, Cooper DA, Carr A: HIV Lipodystrophy Case Definition Study; Australian Lipodystrophy Prevalence Survey Investigators. Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia. Journal of Acquired Immune Deficiency Syndrome: 2005, 38:156-162.
5. Baril J-G, Junod P, LeBlanc R: HIV-associated lipodystrophy syndrome: A review of clinical aspects. The Canadian Journal of Infectious Diseases & Medical Microbiology. 2005; 16(4):233-243.
6. Guallar JP, Gallego-Escuredo JM, Domingo JC, Alegre M, Fontdevila J, Martínez E, Hammond EL, Domingo P, Giralt M, Villarroya F: Differential gene expression indicates that ‘buffalo hump’ is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy: Public Library of Science: 2008, 22:575-584.
This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.